Department of Medicine, Boston Children's Hospital, Boston, MA 02115, USA.
Cell Stem Cell. 2013 Jun 6;12(6):689-98. doi: 10.1016/j.stem.2013.05.008.
Stem cell therapy for cardiac disease is an exciting but highly controversial research area. Strategies such as cell transplantation and reprogramming have demonstrated both intriguing and sobering results. Yet as clinical trials proceed, our incomplete understanding of stem cell behavior is made evident by numerous unresolved matters, such as the mechanisms of cardiomyocyte turnover or the optimal therapeutic strategies to achieve clinical efficacy. In this Perspective, we consider how cardiac stem cell biology has led us into clinical trials, and we suggest that achieving true cardiac regeneration in patients may ultimately require resolution of critical controversies in experimental cardiac regeneration.
心脏疾病的干细胞治疗是一个令人兴奋但极具争议的研究领域。细胞移植和重编程等策略已经展现出了引人入胜和令人警醒的结果。然而,随着临床试验的进行,我们对干细胞行为的理解还不够完善,许多悬而未决的问题也暴露了出来,例如心肌细胞更新的机制或实现临床疗效的最佳治疗策略。在本观点文章中,我们考虑了心脏干细胞生物学是如何引导我们进入临床试验的,并提出在患者中实现真正的心脏再生可能最终需要解决实验性心脏再生中的关键争议。